2018
DOI: 10.1007/s11748-018-1041-8
|View full text |Cite
|
Sign up to set email alerts
|

Angiographic appearance of patent saphenous vein grafts more than 25 years after coronary artery bypass grafting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…The longest duration of a described patent SVG is currently 35 years. 6 Factors associated with improved SVG-LAD patency, from a small retrospective study where the mean SVG age was 30 years, include the target vessel used for grafting, with the LAD artery demonstrating the highest patency rates, good distal run-off, sequential bypass, and strict medical management, including smoking cessation and weight management. 6 Other factors associated with improved SVG patency include no-touch SVG harvesting, the use of buffered SVG storage solutions, and postsurgery pharmacotherapy, including antiplatelet and cholesterol-lowering therapies.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The longest duration of a described patent SVG is currently 35 years. 6 Factors associated with improved SVG-LAD patency, from a small retrospective study where the mean SVG age was 30 years, include the target vessel used for grafting, with the LAD artery demonstrating the highest patency rates, good distal run-off, sequential bypass, and strict medical management, including smoking cessation and weight management. 6 Other factors associated with improved SVG patency include no-touch SVG harvesting, the use of buffered SVG storage solutions, and postsurgery pharmacotherapy, including antiplatelet and cholesterol-lowering therapies.…”
mentioning
confidence: 99%
“… 6 Factors associated with improved SVG-LAD patency, from a small retrospective study where the mean SVG age was 30 years, include the target vessel used for grafting, with the LAD artery demonstrating the highest patency rates, good distal run-off, sequential bypass, and strict medical management, including smoking cessation and weight management. 6 Other factors associated with improved SVG patency include no-touch SVG harvesting, the use of buffered SVG storage solutions, and postsurgery pharmacotherapy, including antiplatelet and cholesterol-lowering therapies. 7 Y-composite graft (SAVE RITA) randomized clinical trial, which compared SVG (harvested using the no-touch technique) to RIMA use as a Y-composite graft off the in situ left internal mammary artery, found similar patency rates compared to RIMA at 10 years.…”
mentioning
confidence: 99%